Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian Women
Valentina A Zavala1, Sandro Casavilca-Zambrano2, Jeannie Navarro-Vásquez2
1Department of Public Health Sciences, University of California Davis, Davis, California.
Summary
A specific genetic variant, rs140068132, is linked to reduced breast cancer risk in Peruvian women. This protective effect is particularly notable for hormone receptor-negative and HER2-positive subtypes.
Area of Science:
- Genetics
- Oncology
- Population Health
Background:
- Breast cancer incidence varies among ethnic groups in the US.
- A known Indigenous American germline variant, rs140068132, near the estrogen receptor 1 gene, shows protective effects.
- This study focuses on Hispanic/Latina women with high Indigenous American ancestry.
Purpose of the Study:
- To investigate the association between the rs140068132 variant and other polymorphisms in the 6q25 region.
- To determine the impact of these variants on subtype-specific breast cancer risk in Hispanic/Latina women.
Main Methods:
- Genotyping of 5,094 Peruvian women (1,755 with breast cancer, 3,337 without).
- Logistic regression and conditional analyses to test genotype-risk associations.
- Inclusion of other risk-associated polymorphisms in the 6q25 region.
Main Results:
- Replication of the association between rs140068132 and overall breast cancer risk reduction (OR, 0.53).
- rs140068132 showed lower odds for hormone receptor-negative (HR-) versus HR+ disease (OR, 0.77).
- Further heterogeneity observed with HER2-positive subtypes, with reduced odds for HR+HER2+ and HR-HER2+ diseases.
Conclusions:
- The rs140068132 polymorphism significantly decreases breast cancer risk in Peruvians.
- The variant offers protection against HR- and HER2+ breast cancer subtypes.
- These findings highlight the importance of genetic diversity in research and could guide functional studies.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.1K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.4K
